N. D'Acosta

728 total citations
20 papers, 624 citations indexed

About

N. D'Acosta is a scholar working on Oncology, Pharmacology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, N. D'Acosta has authored 20 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 8 papers in Pharmacology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in N. D'Acosta's work include Drug-Induced Hepatotoxicity and Protection (7 papers), Drug Transport and Resistance Mechanisms (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). N. D'Acosta is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (7 papers), Drug Transport and Resistance Mechanisms (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). N. D'Acosta collaborates with scholars based in Argentina, United States and Australia. N. D'Acosta's co-authors include E.C. de Ferreyra, C.R. de Castro, M.I. Díaz Gómez, O.M. de Fenos, J.A. Castro, J.A. Castro, Fang Fang, John W. Smith, Ellen Chuang and Elizabeth Tan-Chiu and has published in prestigious journals such as Journal of Clinical Oncology, Biochemical and Biophysical Research Communications and Toxicology and Applied Pharmacology.

In The Last Decade

N. D'Acosta

20 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
N. D'Acosta Argentina	11	301	290	103	77	58	20	624
Jean‐Paul Leroux France	14	127 0.4×	326 1.1×	203 2.0×	62 0.8×	58 1.0×	24	685
R W Bork United States	7	223 0.7×	308 1.1×	240 2.3×	118 1.5×	44 0.8×	7	992
Georg F. Kahl Germany	16	373 1.2×	211 0.7×	269 2.6×	153 2.0×	41 0.7×	34	820
Sidney D. Nelson United States	9	195 0.6×	429 1.5×	176 1.7×	55 0.7×	47 0.8×	9	664
K. N. Ham Australia	10	87 0.3×	205 0.7×	93 0.9×	72 0.9×	50 0.9×	21	569
E Gravela Italy	14	96 0.3×	239 0.8×	272 2.6×	68 0.9×	70 1.2×	39	697
Leslie R. Schwarz Germany	11	374 1.2×	147 0.5×	149 1.4×	48 0.6×	15 0.3×	22	638
Henk Koster Netherlands	14	174 0.6×	286 1.0×	158 1.5×	45 0.6×	42 0.7×	22	701
Janet R. Dawson United Kingdom	13	105 0.3×	162 0.6×	174 1.7×	44 0.6×	34 0.6×	20	515
Josef Gut Switzerland	14	166 0.6×	378 1.3×	170 1.7×	32 0.4×	24 0.4×	24	698

Countries citing papers authored by N. D'Acosta

Since Specialization

Citations

This map shows the geographic impact of N. D'Acosta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. D'Acosta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. D'Acosta more than expected).

Fields of papers citing papers by N. D'Acosta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. D'Acosta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. D'Acosta. The network helps show where N. D'Acosta may publish in the future.

Co-authorship network of co-authors of N. D'Acosta

This figure shows the co-authorship network connecting the top 25 collaborators of N. D'Acosta. A scholar is included among the top collaborators of N. D'Acosta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. D'Acosta. N. D'Acosta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schwartzberg, Lee S., Igor Bondarenko, Sara M. Tolaney, et al.. (2021). Results from CONTESSA 2: A multinational, multicenter, phase 2 study of tesetaxel (T) plus a reduced dose of capecitabine (C) in patients (pts) with hormone receptor + (HR+), HER2- metastatic breast cancer (MBC) not previously treated with a taxane.. Journal of Clinical Oncology. 39(15_suppl). 1061–1061. 1 indexed citations

Tolaney, Sara M., Igor Bondarenko, Arlene Chan, et al.. (2020). CONTESSA TRIO: A multinational, multicenter, phase (P) II study of tesetaxel (T) plus three different PD-(L)1 inhibitors in patients (Pts) with metastatic triple-negative breast cancer (TNBC) and tesetaxel monotherapy in elderly pts with HER2-metastatic breast cancer (MBC).. Journal of Clinical Oncology. 38(15_suppl). TPS1111–TPS1111. 3 indexed citations

Bardia, Aditya, N. D'Acosta, Nashat Gabrail, et al.. (2016). Phase (Ph) 1 study of oral seviteronel (VT-464), a dual CYP17-Lyase (L) inhibitor and androgen receptor (AR) antagonist, in patients (pts) with advanced AR+ triple negative (TNBC) or estrogen receptor (ER)+ breast cancer (BC).. Journal of Clinical Oncology. 34(15_suppl). 1088–1088. 9 indexed citations

Vahdat, Linda T., Brian Pruitt, Carol J. Fabian, et al.. (2009). Phase II Study of Eribulin Mesylate, a Halichondrin B Analog, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane. Journal of Clinical Oncology. 27(18). 2954–2961. 201 indexed citations

Madajewicz, Stefan, Daniela Matei, Andrzej P. Kudelka, et al.. (1999). Actual 5-Year Survival of Patients with Stage IIIB Breast Carcinoma: Phase II Trial of Methotrexate, Vinblastine, Adriamycin, Cisplatin, and Folinic Acid. Cancer Investigation. 17(7). 463–467. 4 indexed citations

D'Acosta, N. & Mae B. Hultin. (1991). Effective therapy of human immunodeficiency virus‐associated anemia with recombinant human erythropoietin despite high endogenous erythropoietin. American Journal of Hematology. 36(1). 71–72. 5 indexed citations

D'Acosta, N., J.A. Castro, C.R. de Castro, et al.. (1975). Mechanismofdimethylnitrosamine and carbon tetrachloride-induced liver necrosis: Similarities and differences. Toxicology and Applied Pharmacology. 32(3). 474–481. 8 indexed citations

Ferreyra, E.C. de, J.A. Castro, M.I. Díaz Gómez, et al.. (1975). Diverse effects of antioxidants on carbon tetrachloride hepatotoxicity. Toxicology and Applied Pharmacology. 32(3). 504–512. 7 indexed citations

Gómez, M.I. Díaz, C.R. de Castro, N. D'Acosta, et al.. (1975). Species differences in carbon tetrachloride-induced hepatotoxicity: The role of CCl4 activation and of lipid peroxidation. Toxicology and Applied Pharmacology. 34(1). 102–114. 76 indexed citations

10.

Ja, Castro, et al.. (1975). Carbon tetrachloride induced polysome breakdown. Relative importance of lipid peroxidation and of binding to ribosomal components in the process.. PubMed. 10(1). 93–104. 9 indexed citations

11.

Ferreyra, E.C. de, J.A. Castro, M.I. Díaz Gómez, et al.. (1974). Prevention and treatment of carbon tetrachloride hepatotoxicity by cysteine: Studies about its mechanism. Toxicology and Applied Pharmacology. 27(3). 558–568. 44 indexed citations

12.

Castro, J.A., N. D'Acosta, E.C. de Ferreyra, et al.. (1974). Studies on thioacetamide-induced liver necrosis. Toxicology and Applied Pharmacology. 30(1). 79–86. 22 indexed citations

13.

Castro, J.A., et al.. (1973). Differences in the carbon tetrachloride-induced damage to components of the smooth and rough endoplasmic reticulum from rat liver. Biochemical and Biophysical Research Communications. 50(2). 337–343. 13 indexed citations

14.

Gómez, M.I. Díaz, J.A. Castro, E.C. de Ferreyra, N. D'Acosta, & C.R. de Castro. (1973). Irreversible binding of 14C from 14CCl4 to liver microsomal lipids and proteins from rats pretreated with compounds altering microsomal mixed-function oxygenase activity. Toxicology and Applied Pharmacology. 25(4). 534–541. 69 indexed citations

15.

Castro, JoséA., E.C. de Ferreyra, C.R. de Castro, et al.. (1973). Studies on the mechanism of cystamine prevention of several liver structural and biochemical alterations caused by carbon tetrachloride. Toxicology and Applied Pharmacology. 24(1). 1–19. 63 indexed citations

16.

D'Acosta, N., et al.. (1973). Role of cytochrome P-450 in carbon tetrachloride activation and CCl 4-induced necrosis. Effect of inhibitors of heme synthesis. I. 3-Amino-1,2,4 triazole.. PubMed. 6(1). 175–83. 14 indexed citations

17.

Castro, J.A., C.R. de Castro, N. D'Acosta, M.I. Díaz Gómez, & E.C. de Ferreyra. (1973). Carbon tetrachloride activation in liver microsomes from rats induced with 3-methylcholantrene. Biochemical and Biophysical Research Communications. 50(2). 273–279. 18 indexed citations

18.

Castro, J.A., C.R. de Castro, O.M. de Fenos, et al.. (1972). Effect of cystamine on the mixed-function oxygenase system from rat liver microsomes and its preventive effect on the destruction of cytochrome P-450 by carbon tetrachloride. Pharmacological Research Communications. 4(3). 185–190. 9 indexed citations

19.

D'Acosta, N., et al.. (1972). Pyrazole blockade of carbon tetrachloride activation and liver necrosis.. PubMed. 4(3). 641–50. 13 indexed citations

20.

Castro, J.A., et al.. (1972). Carbon tetrachloride effect on rat liver and adrenals related to their mixedfunction oxygenase content. Biochemical and Biophysical Research Communications. 47(2). 315–321. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact